A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers

NCT03038711 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: BMS-986166
OTHER: Placebo matching BMS-986166

Sponsor

Bristol-Myers Squibb